Abound Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Sell
780
-173
-18% -$52.5K 0.07% 66
2026
Q1
$204K Buy
953
+22
+2% +$4.92K 0.05% 92
2025
Q4
$159K Buy
931
+60
+7% +$9.33K 0.04% 102
2025
Q3
$117K Hold
871
0.03% 121
2025
Q2
$84.7K Buy
871
+29
+3% +$2.3K 0.02% 144
2025
Q1
$61.2K Sell
842
-80
-9% -$6.3K 0.02% 162
2024
Q4
$66.6K Buy
922
+2
+0.2% +$152 0.02% 147
2024
Q3
$75.3K Buy
920
+170
+23% +$14.8K 0.03% 129
2024
Q2
$80.1K Hold
750
0.03% 107
2024
Q1
$73.1K Hold
750
0.03% 111
2023
Q4
$58.7K Buy
750
+20
+3% +$1.36K 0.02% 131
2023
Q3
$45.8K Hold
730
0.02% 144
2023
Q2
$46.9K Buy
730
+70
+11% +$3.95K 0.02% 137
2023
Q1
$35K Hold
660
0.02% 159
2022
Q4
$27.7K Buy
660
+70
+12% +$2.93K 0.01% 163
2022
Q3
$21.6K Buy
+590
New +$26.3K 0.01% 178

Other funds holding LRCX

Abound Wealth Management's LRCX Position: Q2 2026 in Review

Abound Wealth Management reduced its Lam Research (LRCX) stake by 18% in Q2 2026, selling an estimated $52.5K and leaving 780 shares worth $338K. The position accounts for 0.07% of the portfolio, ranked #66.

Abound Wealth Management first reported a position in LRCX in Q3 2022 and has held it in 16 quarters since. 3,129 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Abound Wealth Management held 780 shares of Lam Research worth $338K as of Q2 2026.
  • Abound Wealth Management sold 173 Lam Research shares in Q2 2026, an estimated $52.5K.
  • Lam Research made up 0.07% of Abound Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Abound Wealth Management first reported a position in Lam Research in Q3 2022 and has held it in 16 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.